Nuzyra 150 MG tablet UD 30S
Ended Awarded
- Contract number
- SPE2DB25FJ5KL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,144
Award facts
- Contract value 100% obligated
- $20,143.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,143.72 delivery order to AmerisourceBergen Drug Corp for the supply of NUZYRA 150 mg tablets in unit dose packaging (30-count) with a firm fixed price structure. The contract, awarded on September 26, 2025, is set to conclude by October 20, 2025, with performance occurring at the contractor's Conshohocken, Pennsylvania facility. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle designated as SPE2DX that extends through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected without set-aside provisions to fulfill this medical supply requirement. As a critical federal vendor for the Defense Logistics Agency's Medical Supply Chain, the company demonstrates extensive capability in delivering brand-name pharmaceuticals, generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Department of Defense and veteran healthcare systems. This award reflects AmerisourceBergen's ongoing role as a preferred supplier within the DLA's pharmaceutical procurement infrastructure, enabling the agency to maintain reliable access to essential medications for military and defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FJ5KL?
SPE2DB25FJ5KL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FJ5KL worth?
The government has obligated $20,144 on SPE2DB25FJ5KL.
Is contract SPE2DB25FJ5KL an order under another contract?
Yes. SPE2DB25FJ5KL is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ5KL competed?
The extent of competition for SPE2DB25FJ5KL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award